[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Page 57458]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Workshop

    Notice is hereby given of a workshop convened by the National 
Center for Advancing Translational Sciences Cures Acceleration Network 
Review Board.

Purpose

    The National Center for Advancing Translational Sciences is hosting 
the Cures Acceleration Network Review Board (CAN RB) Workshop: The CAN 
RB advises and provides recommendations to the NCATS Director with 
respect to significant barriers to successful translation of basic 
science into clinical application. In support of this mandate, the CAN 
RB will co-host this public workshop to discuss challenges around 
finding new uses for drugs that are already on the market but lack 
commercial and regulatory incentives for research and development.
    The Workshop is being co-sponsored by the NCATS Cures Acceleration 
Network Review Board, NCATS Drug Development Partnership Programs, Food 
and Drug Administration, and Reagan-Udall Foundation for the FDA.
    Name of Committee: National Center for Advancing Translational 
Sciences Cures Acceleration Network Review Board.
    Type of Meeting: Repurposing Off-Patent Drugs: Research & 
Regulatory Challenges.
    Date: December 5-6, 2019.
    Time: 7:30 a.m. to 5:00 p.m., Eastern Standard Time (EST).
    Agenda: The Workshop will assess challenges around finding new uses 
for drugs that are already on the market but lack commercial and 
regulatory incentives for research and development. On December 5, we 
will map out the challenges to repurposing off-patent drugs. On 
December 6, we will host interactive work sessions focused on capturing 
possible solutions.
    Place: Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Cost: The meeting is free and open to the public.
    Registration: Registration is required. Using the link below, 
attendees can register by December 2, 2019, 5:00 p.m. EST. Early 
registration is recommended due to limited seating. https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/index.html.
    Access: Twinbrook Metro Station (Red Line).
    Contact Person: Bobbie Ann Mount, Ph.D., Program Officer, Drug 
Development Partnership Programs, Office of the Director, National 
Center for Advancing Translational Sciences, National Institutes of 
Health. Telephone: 301.435.0824, Email: 
[email protected].

    Disability Accommodations: Individuals whose full participation in 
the workshop will require special accommodations (e.g., sign language, 
or interpreting services, etc.) must submit a request to the Contact 
Person listed on the notice at least ten (10) business days prior to 
the meeting. Such requests should include a detailed description of the 
accommodation needed and a way to contact the requester if more 
information is needed to fill the request. Special requests should be 
made as early as possible. Last minute requests may be made but may not 
be possible to accommodate.
    Security: Visitors will be asked to show one form of identification 
(for example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit. Also, as a part of 
security procedures, attendees should be prepared to present a photo ID 
at the meeting registration desk during the check-in process. Pre-
registration is recommended. Seating will be limited to the room 
capacity and seats will be on a first come, first serve basis, with 
expedited check-in for those who are pre-registered.
    Meeting schedule subject to change.
    For more information, visit: https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/index.html.

    Dated: October 21, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-23280 Filed 10-24-19; 8:45 am]
 BILLING CODE 4140-01-P